Heterodimerisation of G protein-coupled receptors: implications for drug design and ligand screening

Bibliography

• Spiegel AM. Defects in G protein-coupled signal transduction in human disease. Annu Rev Physiol 1996;58:143-70
   PubMed Web of Science ®Google Scholar
• Bockaert J, Pin JP. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J 1999;18(7):1723-9
   PubMed Web of Science ®Google Scholar
• Han Y, Moreira IS, Urizar E, Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation. Nat Chem Biol 2009;5(9):688-95
   PubMed Web of Science ®Google Scholar
• Reddy PS, Corley RB. Assembly, sorting, and exit of oligomeric proteins from the endoplasmic reticulum. Bioessays 1998;20(7):546-54
   PubMed Web of Science ®Google Scholar
• Angers S, Salahpour A, Joly E, Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci USA 2000;97(7):3684-9
   PubMed Web of Science ®Google Scholar
• Cheng ZJ, Miller LJ. Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. J Biol Chem 2001;276(51):48040-7
   PubMed Web of Science ®Google Scholar
• Kroeger KM, Hanyaloglu AC, Seeber RM, Constitutive and agonist-dependent homo-oligomerization of the thyrotropin-releasing hormone receptor. Detection in living cells using bioluminescence resonance energy transfer. J Biol Chem 2001;276(16):12736-43
   PubMed Web of Science ®Google Scholar
• Pin JP, Neubig R, Bouvier M, International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers. Pharmacol Rev 2007;59(1):5-13
   PubMed Web of Science ®Google Scholar
• Ferre S, Baler R, Bouvier M, Building a new conceptual framework for receptor heteromers. Nat Chem Biol 2009;5(3):131-4
   PubMed Web of Science ®Google Scholar
• George SR, O'Dowd BF, Lee SP. G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat Rev Drug Discov 2002;1(10):808-20
   PubMed Web of Science ®Google Scholar
• Lee SP, O'Dowd BF, Ng GY, Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell. Mol Pharmacol 2000;58(1):120-8
   PubMed Web of Science ®Google Scholar
• Chidiac P, Green MA, Pawagi AB, Wells JW. Cardiac muscarinic receptors. Cooperativity as the basis for multiple states of affinity. Biochemistry 1997;36(24):7361-79
   PubMed Web of Science ®Google Scholar
• Lopez-Gimenez JF, Canals M, Pediani JD, Milligan G. The alpha1b-adrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery, and function. Mol Pharmacol 2007;71(4):1015-29
   PubMed Web of Science ®Google Scholar
• Carrillo JJ, Lopez-Gimenez JF, Milligan G. Multiple interactions between transmembrane helices generate the oligomeric alpha1b-adrenoceptor. Mol Pharmacol 2004;66(5):1123-37
   PubMed Web of Science ®Google Scholar
• Liang Y, Fotiadis D, Filipek S, Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J Biol Chem 2003;278(24):21655-62
   PubMed Web of Science ®Google Scholar
• Overton MC, Chinault SL, Blumer KJ. Oligomerization, biogenesis, and signaling is promoted by a glycophorin A-like dimerization motif in transmembrane domain 1 of a yeast G protein-coupled receptor. J Biol Chem 2003;278(49):49369-77
   PubMed Web of Science ®Google Scholar
• Guo W, Shi L, Filizola M, Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. Proc Natl Acad Sci USA 2005;102(48):17495-500
   PubMed Web of Science ®Google Scholar
• Thevenin D, Lazarova T, Roberts MF, Robinson CR. Oligomerization of the fifth transmembrane domain from the adenosine A2A receptor. Protein Sci 2005;14(8):2177-86
   PubMed Web of Science ®Google Scholar
• White JH, Wise A, Main MJ, Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 1998;396(6712):679-82
   PubMed Web of Science ®Google Scholar
• AbdAlla S, Zaki E, Lother H, Quitterer U. Involvement of the amino terminus of the B(2) receptor in agonist-induced receptor dimerization. J Biol Chem 1999;274(37):26079-84
   PubMed Web of Science ®Google Scholar
• Cvejic S, Devi LA. Dimerization of the delta opioid receptor: implication for a role in receptor internalization. J Biol Chem 1997;272(43):26959-64
   PubMed Web of Science ®Google Scholar
• AbdAlla S, Lother H, el Massiery A, Quitterer U. Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med 2001;7(9):1003-9
   PubMed Web of Science ®Google Scholar
• Shioda T, Nakayama EE, Tanaka Y, Naturally occurring deletional mutation in the C-terminal cytoplasmic tail of CCR5 affects surface trafficking of CCR5. J Virol 2001;75(7):3462-8
   PubMed Web of Science ®Google Scholar
• Wilson S, Wilkinson G, Milligan G. The CXCR1 and CXCR2 receptors form constitutive homo- and heterodimers selectively and with equal apparent affinities. J Biol Chem 2005;280(31):28663-74
   PubMed Web of Science ®Google Scholar
• Canals M, Lopez-Gimenez JF, Milligan G. Cell surface delivery and structural re-organization by pharmacological chaperones of an oligomerization-defective alpha(1b)-adrenoceptor mutant demonstrates membrane targeting of GPCR oligomers. Biochem J 2009;417(1):161-72
   PubMedGoogle Scholar
• Brown D, Breton S. Sorting proteins to their target membranes. Kidney Int 2000;57(3):816-24
   PubMed Web of Science ®Google Scholar
• Kim PS, Arvan P. Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones. Endocr Rev 1998;19(2):173-202
   PubMed Web of Science ®Google Scholar
• Breit A, Lagace M, Bouvier M. Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties. J Biol Chem 2004;279(27):28756-65
   PubMed Web of Science ®Google Scholar
• Xu J, He J, Castleberry AM, Heterodimerization of alpha 2A- and beta 1-adrenergic receptors. J Biol Chem 2003;278(12):10770-7
   PubMed Web of Science ®Google Scholar
• Stanasila L, Perez JB, Vogel H, Cotecchia S. Oligomerization of the alpha 1a- and alpha 1b-adrenergic receptor subtypes. Potential implications in receptor internalization. J Biol Chem 2003;278(41):40239-51
   PubMed Web of Science ®Google Scholar
• George SR, Fan T, Xie Z, Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J Biol Chem 2000;275(34):26128-35
   PubMed Web of Science ®Google Scholar
• Lee SP, So CH, Rashid AJ, Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 2004;279(34):35671-8
   PubMed Web of Science ®Google Scholar
• Hilairet S, Bouaboula M, Carriere D, Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716. J Biol Chem 2003;278(26):23731-7
   PubMed Web of Science ®Google Scholar
• Jordan BA, Devi LA. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 1999;399(6737):697-700
   PubMed Web of Science ®Google Scholar
• Waldhoer M, Fong J, Jones RM, A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. Proc Natl Acad Sci USA 2005;102(25):9050-5
   PubMed Web of Science ®Google Scholar
• Milasta S, Pediani J, Appelbe S, Interactions between the Mas-related receptors MrgD and MrgE alter signalling and trafficking of MrgD. Mol Pharmacol 2006;69(2):479-91
   PubMed Web of Science ®Google Scholar
• Hosoi T, Koguchi Y, Sugikawa E, Identification of a novel human eicosanoid receptor coupled to G(i/o). J Biol Chem 2002;277(35):31459-65
   PubMed Web of Science ®Google Scholar
• Takeda S, Yamamoto A, Okada T, Identification of surrogate ligands for orphan G protein-coupled receptors. Life Sci 2003;74(2-3):367-77
   PubMed Web of Science ®Google Scholar
• Wenzel-Seifert K, Seifert R. Properties of Arg389-beta1-adrenoceptor-Gsalpha fusion proteins: comparison with Gly389-beta1-adrenoceptor-Gsalpha fusion proteins. Receptors Channels 2003;9(5):315-23
   PubMedGoogle Scholar
• Milligan G. Insights into ligand pharmacology using receptor-G-protein fusion proteins. Trends Pharmacol Sci 2000;21(1):24-8
   PubMed Web of Science ®Google Scholar
• Milligan G. The use of receptor G-protein fusion proteins for the study of ligand activity. Receptors Channels 2002;8(5-6):309-17
   PubMedGoogle Scholar
• Milligan G, Feng GJ, Ward RJ, G protein-coupled receptor fusion proteins in drug discovery. Curr Pharm Des 2004;10(17):1989-2001
   PubMed Web of Science ®Google Scholar
• Milligan G, Parenty G, Stoddart LA, Lane JR. Novel pharmacological applications of G-protein-coupled receptor-G protein fusions. Curr Opin Pharmacol 2007;7(5):521-6
   PubMed Web of Science ®Google Scholar
• Fong CW, Milligan G. Analysis of agonist function at fusion proteins between the IP prostanoid receptor and cognate, unnatural and chimaeric G-proteins. Biochem J 1999;342(Pt 2):457-63
   PubMedGoogle Scholar
• Barclay E, O'Reilly M, Milligan G. Activation of an alpha2A-adrenoceptor-Galphao1 fusion protein dynamically regulates the palmitoylation status of the G protein but not of the receptor. Biochem J 2005;385(Pt 1):197-206
   PubMedGoogle Scholar
• Stoddart LA, Brown AJ, Milligan G. Uncovering the pharmacology of the G protein-coupled receptor GPR40: high apparent constitutive activity in guanosine 5′-O-(3-[35S]thio)triphosphate binding studies reflects binding of an endogenous agonist. Mol Pharmacol 2007;71(4):994-1005
   PubMed Web of Science ®Google Scholar
• Zhang L, DiLizio C, Kim D, The G12 family of G proteins as a reporter of thromboxane A2 receptor activity. Mol Pharmacol 2006;69(4):1433-40
   PubMed Web of Science ®Google Scholar
• Bertin B, Freissmuth M, Jockers R, Cellular signaling by an agonist-activated receptor/Gs alpha fusion protein. Proc Natl Acad Sci USA 1994;91(19):8827-31
   PubMed Web of Science ®Google Scholar
• Hildebrandt JD. Bring your own G protein. Mol Pharmacol 2006;69(4):1079-82
   PubMed Web of Science ®Google Scholar
• Perez DM, Karnik SS. Multiple signaling states of G-protein-coupled receptors. Pharmacol Rev 2005;57(2):147-61
   PubMed Web of Science ®Google Scholar
• Kenakin T. Inverse, protean, and ligand-selective agonism: matters of receptor conformation. FASEB J 2001;15(3):598-611
   PubMed Web of Science ®Google Scholar
• Urban JD, Clarke WP, von Zastrow M, Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther 2007;320(1):1-13
   PubMed Web of Science ®Google Scholar
• Lane JR, Powney B, Wise A, Protean agonism at the dopamine D2 receptor: (S)-3-(3-hydroxyphenyl)-N-propylpiperidine is an agonist for activation of Go1 but an antagonist/inverse agonist for Gi1,Gi2, and Gi3. Mol Pharmacol 2007;71(5):1349-59
   PubMed Web of Science ®Google Scholar
• Carrillo JJ, Pediani J, Milligan G. Dimers of class A G protein-coupled receptors function via agonist-mediated trans-activation of associated G proteins. J Biol Chem 2003;278(43):42578-87
   PubMed Web of Science ®Google Scholar
• Pascal G, Milligan G. Functional complementation and the analysis of opioid receptor homodimerization. Mol Pharmacol 2005;68(3):905-15
   PubMed Web of Science ®Google Scholar
• Jans DA, Xiao CY, Lam MH. Nuclear targeting signal recognition: a key control point in nuclear transport? Bioessays 2000;22(6):532-44
   PubMed Web of Science ®Google Scholar
• Lu D, Yang H, Shaw G, Raizada MK. Angiotensin II-induced nuclear targeting of the angiotensin type 1 (AT1) receptor in brain neurons. Endocrinology 1998;139(1):365-75
   PubMed Web of Science ®Google Scholar
• Lee DK, Lanca AJ, Cheng R, Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors. J Biol Chem 2004;279(9):7901-8
   PubMed Web of Science ®Google Scholar
• O'Dowd BF, Ji X, Alijaniaram M, Dopamine receptor oligomerization visualized in living cells. J Biol Chem 2005;280(44):37225-35
   PubMed Web of Science ®Google Scholar
• O'Dowd BF, Alijaniaram M, Ji X, Using ligand-induced conformational change to screen for compounds targeting G-protein-coupled receptors. J Biomol Screen 2007;12(2):175-85
   PubMed Web of Science ®Google Scholar
• Juhasz JR, Hasbi A, Rashid AJ, Mu-opioid receptor heterooligomer formation with the dopamine D1 receptor as directly visualized in living cells. Eur J Pharmacol 2008;581(3):235-43
   PubMed Web of Science ®Google Scholar
• Stoffel RH, 3rd, Pitcher JA, Lefkowitz RJ. Targeting G protein-coupled receptor kinases to their receptor substrates. J Membr Biol 1997;157(1):1-8
   PubMed Web of Science ®Google Scholar
• Luttrell LM, Lefkowitz RJ. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 2002;115(Pt 3):455-65
   PubMed Web of Science ®Google Scholar
• Shenoy SK, Lefkowitz RJ. Seven-transmembrane receptor signaling through beta-arrestin. Sci STKE 2005;2005(308):cm10-
   PubMedGoogle Scholar
• Kendall RT, Luttrell LM. Diversity in arrestin function. Cell Mol Life Sci 2009;66(18):2953-73
   PubMed Web of Science ®Google Scholar
• Gurevich VV, Gurevich EV. The structural basis of arrestin-mediated regulation of G-protein-coupled receptors. Pharmacol Ther 2006;110(3):465-502
   PubMed Web of Science ®Google Scholar
• Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by beta-arrestins. Science 2005;308(5721):512-7
   PubMed Web of Science ®Google Scholar
• Kovacs JJ, Hara MR, Davenport CL, Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways. Dev Cell 2009;17(4):443-58
   PubMed Web of Science ®Google Scholar
• Dromey JR, Pfleger KD. G protein coupled receptors as drug targets: the role of beta-arrestins. Endocr Metab Immune Disord Drug Targets 2008;8(1):51-61
   PubMedGoogle Scholar
• Shenoy SK, Lefkowitz RJ. Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem J 2003;375(Pt 3):503-15
   PubMedGoogle Scholar
• Oakley RH, Laporte SA, Holt JA, Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J Biol Chem 2000;275(22):17201-10
   PubMed Web of Science ®Google Scholar
• Kocan M, See HB, Seeber RM, Demonstration of improvements to the bioluminescence resonance energy transfer (BRET) technology for the monitoring of G protein-coupled receptors in live cells. J Biomol Screen 2008;13(9):888-98
   PubMed Web of Science ®Google Scholar
• Hamdan FF, Audet M, Garneau P, High-throughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based beta-arrestin2 recruitment assay. J Biomol Screen 2005;10(5):463-75
   PubMed Web of Science ®Google Scholar
• Pfleger KD, Dalrymple MB, Dromey JR, Eidne KA. Monitoring interactions between G-protein-coupled receptors and beta-arrestins. Biochem Soc Trans 2007;35(Pt 4):764-6
   PubMedGoogle Scholar
• Pfleger KD, Seeber RM, Eidne KA. Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions. Nat Protocol 2006;1(1):337-45
   PubMed Web of Science ®Google Scholar
• Pfleger KD, Eidne KA. Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET). Nat Methods 2006;3(3):165-74
   PubMed Web of Science ®Google Scholar
• Milligan G, Bouvier M. Methods to monitor the quaternary structure of G protein-coupled receptors. FEBS J 2005;272(12):2914-25
   PubMed Web of Science ®Google Scholar
• Pfleger KD, Dromey JR, Dalrymple MB, Extended bioluminescence resonance energy transfer (eBRET) for monitoring prolonged protein-protein interactions in live cells. Cell Signal 2006;18(10):1664-70
   PubMed Web of Science ®Google Scholar
• Milligan G. Applications of bioluminescence- and fluorescence resonance energy transfer to drug discovery at G protein-coupled receptors. Eur J Pharm Sci 2004;21(4):397-405
   PubMed Web of Science ®Google Scholar
• DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK. Beta-arrestins and cell signaling. Annu Rev Physiol 2007;69:483-510
   PubMed Web of Science ®Google Scholar
• van Koppen CJ, Jakobs KH. Arrestin-independent internalization of G protein-coupled receptors. Mol Pharmacol 2004;66(3):365-7
   PubMed Web of Science ®Google Scholar
• Perroy J, Adam L, Qanbar R, Phosphorylation-independent desensitization of GABA(B) receptor by GRK4. EMBO J 2003;22(15):3816-24
   PubMed Web of Science ®Google Scholar
• Hanyaloglu AC, Seeber RM, Kohout TA, Homo- and hetero-oligomerization of thyrotropin-releasing hormone (TRH) receptor subtypes. Differential regulation of beta-arrestins 1 and 2. J Biol Chem 2002;277(52):50422-30
   PubMed Web of Science ®Google Scholar
• Ayoub MA, Pfleger KD. Recent advances in bioluminescence resonance energy transfer technologies to study GPCR heteromerization. Curr Opin Pharmacol 2010;10(1):44-52
   PubMed Web of Science ®Google Scholar
• Zabin I, Villarejo MR. Protein complementation. Annu Rev Biochem 1975;44:295-313
   PubMed Web of Science ®Google Scholar
• Juers DH, Jacobson RH, Wigley D, High resolution refinement of beta-galactosidase in a new crystal form reveals multiple metal-binding sites and provides a structural basis for alpha-complementation. Protein Sci 2000;9(9):1685-99
   PubMed Web of Science ®Google Scholar
• Eglen RM. Enzyme fragment complementation: a flexible high throughput screening assay technology. Assay Drug Dev Technol 2002;1(1 Pt 1):97-104
   PubMed Web of Science ®Google Scholar
• Eglen RM, Singh R. Beta galactosidase enzyme fragment complementation as a novel technology for high throughput screening. Comb Chem High Throughput Screen 2003;6(4):381-7
   PubMed Web of Science ®Google Scholar
• Buttner FH, Kumpf R, Menzel S, Evaluation of the InteraX system technology in a high-throughput screening environment. J Biomol Screen 2005;10(5):485-94
   PubMed Web of Science ®Google Scholar
• Gouldson PR, Dean MK, Snell CR, Lipid-facing correlated mutations and dimerization in G-protein coupled receptors. Protein Eng 2001;14(10):759-67
   PubMedGoogle Scholar
• Bakker RA, Dees G, Carrillo JJ, Domain swapping in the human histamine H1 receptor. J Pharmacol Exp Ther 2004;311(1):131-8
   PubMed Web of Science ®Google Scholar